Table 4.
Age years | % Seroprotection* | Region | Reference |
---|---|---|---|
1 | 92 | Palestine | This study |
1 | 90 | Alaska | 38 |
2–6 years | |||
4–6 | 86 | Germany | 36 |
4–5 | 85 | Germany | 37 |
5 | 83 | Taiwan | 39 |
2–6 | 76 | Palestine | This study |
6 | 50 | Hawaii | 35 |
5 | 41 | Alaska | 38 |
2.5 | 40 | Micronesia | 19 |
7–12 years | |||
12 | 81 | Hong Kong | 42 |
7–9 | 78 | Germany | 36 |
7 | 71 | Taiwan | 49 |
10.5 | 64 | Italy | 25 |
6–10 | 56–65 | Thailand | 50 |
10–11 | 58 | Iran | 24 |
7–12 | 53 | Palestine | This study |
12 | 37 | Taiwan | 49 |
13–18 years | |||
13–19 | 40 | Palestine | This study |
16–18 | 38 | Saudi Arabia | 43 |
15.5 | 7 | Micronesia | 19 |
Anti-HBs titer ≥10 mIU/mL.